retatrutide triple agonist clinical trial produces up to 30.3% weight loss in Phase 3 Retatrutide is a triple-agonist (GLP-1
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




















